Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Tang

Showing results (631-640 of 635) with videos related to

Pageof 64
Sort By:
You have reached the last page of results.This site can display upto 635 results.
Cell Research|December 2, 2020
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal modelsGan Wang, Meng-Li Yang, Zi-Lei Duan, et al.
Nature Communications|December 8, 2025
Monitoring rapid degradation of NANOG reveals UTP15 maintains pluripotency by regulating nascent transcriptsMingqiang Deng, Dongmei He, Xiwei Wang, et al.
Medcomm|December 11, 2023
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancerQiyun Shi, Xiaowei Qi, Peng Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2019
Cholecystokinin release triggered by NMDA receptors produces LTP and sound-sound associative memoryXi Chen, Xiao Li, Yin Ting Wong, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Pageof 64

Showing results (631-640 of 635) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 635 results.
Cell Research|December 2, 2020
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal modelsGan Wang, Meng-Li Yang, Zi-Lei Duan, et al.
Nature Communications|December 8, 2025
Monitoring rapid degradation of NANOG reveals UTP15 maintains pluripotency by regulating nascent transcriptsMingqiang Deng, Dongmei He, Xiwei Wang, et al.
Medcomm|December 11, 2023
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancerQiyun Shi, Xiaowei Qi, Peng Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2019
Cholecystokinin release triggered by NMDA receptors produces LTP and sound-sound associative memoryXi Chen, Xiao Li, Yin Ting Wong, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Pageof 64